Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 779

Sort by

Sort Order Select

Journal Articles

Next-generation FVIIIa-mimetic bispecific antibody NXT007: evaluation in preclinical models of hemostasis and thrombosis

Matthew Locke, Jamie Albiez, Nicolas Receveur, Sandra Marbach, Nina Frey, Mukul Girotra, Mariella Wyssenbach, Lejla Bektic, Tovo David

Blood Adv bloodadvances.2025018215.

https://doi.org/10.1182/bloodadvances.2025018215

Published: 2025

Includes: Multimedia, Supplemental data

Journal Articles

Deferral of immunosuppression in acquired hemophilia

Jerome Teitel, Jean St-Louis

Blood Adv (2025) 9 (22): 5913–5914.

https://doi.org/10.1182/bloodadvances.2025017953

Published: 2025

Journal Articles

Beyond platelet counts: assessing safety of postsplenectomy TPO-RA use in ITP

Ruah Alyamany, Damon E. Houghton, Meera Sridharan, Rajiv K. Pruthi, Surbhi Shah, Richard C. Godby, Alexandra Wolanskyj-Spinner, Ronald S. Go

Blood Adv (2025) 9 (22): 5902–5912.

https://doi.org/10.1182/bloodadvances.2025017902

Published: 2025

Includes: Supplemental data

Journal Articles

Diagnosis of von Willebrand disease

Mackenzie Bowman, Paula James

Blood Adv (2025) 9 (22): 5870–5879.

https://doi.org/10.1182/bloodadvances.2025016485

Published: 2025

Journal Articles

FcR γ-chain and platelet hyperactivity

Roy L. Silverstein

Blood Adv (2025) 9 (22): 5790–5791.

https://doi.org/10.1182/bloodadvances.2025017581

Published: 2025

Journal Articles

Sustained survival benefit of emicizumab and postponed immunosuppression in acquired hemophilia A

Inga M. Schimansky, Christiane Dobbelstein, Robert Klamroth, Christina Hart, Ulrich J. Sachs, Richard Greil, Paul Knöbl, Johannes Oldenburg, Wolfgang Miesbach, Christian Pfrepper, Karolin Trautmann-Grill, Patrick Möhnle, Katharina Holstein, Hermann Eichler, Sonja Werwitzke, Andreas Tiede

Blood Adv (2025) 9 (22): 5853–5860.

https://doi.org/10.1182/bloodadvances.2025017144

Published: 2025

Includes: Supplemental data

Journal Articles

Treatment of von Willebrand Disease

Nathan T Connell

Blood Adv bloodadvances.2025016487.

https://doi.org/10.1182/bloodadvances.2025016487

Published: 2025

Journal Articles

Hypoxia-inducible Factors Contribute to Venous Thrombosis in a Mouse Model of Myeloproliferative Neoplasms

Shatadal Ghosh, Joanna Miklosz, Fatima Trebak, Julie Tourn, Steven P Grover, Rafal Pawlinski, Brandi N. Reeves

Blood Adv bloodadvances.2025016344.

https://doi.org/10.1182/bloodadvances.2025016344

Published: 2025

Journal Articles

Bleeding and Thrombotic Outcomes in Patients With Inflammatory Bowel Disease and Venous Thromboembolism

Ghadeer K. Dawwas, Adam Cuker, James D. Lewis

Blood Adv bloodadvances.2025017617.

https://doi.org/10.1182/bloodadvances.2025017617

Published: 2025

Includes: Supplemental data

Journal Articles

Phosphorylation at Y317 on Syk negatively regulates both ITAM- and hemITAM-mediated signaling and function in platelets

Manal A. Elzoheiry, Carol A. Dangelmaier, Dhruv N. Vajipayajula, Monica N. Wright, Alexander Y. Tsygankov, Satya P. Kunapuli

Blood Adv (2025) 9 (21): 5626–5637.

https://doi.org/10.1182/bloodadvances.2025016714

Published: 2025

Includes: Supplemental data

Journal Articles

Outcomes of patients with suspected heparin-induced thrombocytopenia in a contemporary multicenter cohort

Henning Nilius, Ekaterina Sinitsa, Jan-Dirk Studt, Dimitrios A. Tsakiris, Andreas Greinacher, Adriana Mendez, Adrian Schmidt, Walter A. Wuillemin, Bernhard Gerber, Prakash Vishnu, Lukas Graf, Johanna A. Kremer Hovinga, Tamam Bakchoul, Michael Nagler

Blood Adv (2025) 9 (21): 5546–5555.

https://doi.org/10.1182/bloodadvances.2025016639

Published: 2025

Includes: Supplemental data

Journal Articles

Efficacy and safety of thrombolysis for pediatric venous thromboembolism: a systematic review and meta-analysis

Blood Adv (2025) 9 (21): 5512–5527.

https://doi.org/10.1182/bloodadvances.2025017058

Published: 2025

Includes: Supplemental data

Journal Articles

A disrupted adenosinergic axis facilitates platelet activation in APS: exploring a novel therapeutic target

Somanathapura K. NaveenKumar, Thalia G. Newman, Bruna Mazetto Fonseca, Srilakshmi Yalavarthi, Mariane C. Flores Nascimento, Kaitlyn Sabb, Katarina Kmetova, Emily Chong, Kavya Sugur, Caroline H. Ranger, Megan P. Tompkins, Cyrus Sarosh, Jacqueline A. Madison, Ajay Tambralli, Jordan K. Schaefer, Michael Holinstat, Yu Zuo, Jason S. Knight

Blood Adv (2025) 9 (21): 5423–5435.

https://doi.org/10.1182/bloodadvances.2025016162

Published: 2025

Includes: Supplemental data

Journal Articles

The Na/K-ATPase Alpha-1 Subunit Fine-Tunes Platelet P2Y12 Function and Mediates Sex-Dimorphism-Associated Thrombosis

Oliver Q Li, Hong Yue, Autumn DeHart, Renat Roytenberg, Angela Li, Fang Bai, Hongyu Su, Rodrigo Aguilar, Olalekan Olanipekun, Jiang Liu, Olga Fedorova, David Kennedy, Ellen Thompson, Jordan A Shavit, Sandrine V Pierre, Wei Li

Blood Adv bloodadvances.2025016605.

https://doi.org/10.1182/bloodadvances.2025016605

Published: 2025

Includes: Multimedia, Supplemental data

Journal Articles

Pyruvate kinase M2 promotes venous thrombosis by enhancing SNAP23-mediated platelet exocytosis and consequent NETosis

Manasa K. Nayak, Gagan D Flora, Ivan Budnik, Tarun Barbhuyan, Rakesh B. Patel, Madankumar Ghatge, Mariia Kumskova, Aditi Jain, Neelam Chauhan, Jitendra Kumar, Megan Jewell, Santosh Kumar, Steven R Lentz, Keith B Neeves, Anil Chauhan

Blood Adv bloodadvances.2025017414.

https://doi.org/10.1182/bloodadvances.2025017414

Published: 2025

Includes: Supplemental data

Journal Articles

Modeling Response to High-Purity Von Willebrand Factor: Toward Tailored Dosing During Surgery in von Willebrand Disease

Melanie Y Daniel, Antoine Rauch, Camille Paris, Emmanuelle Jeanpierre, Jenny Goudemand, Catherine Marichez, Benedicte Pradines, Christophe Zawadzki, Annabelle Dupont, Cécile V. Denis, Peter J Lenting, Sophie Susen, Xavier Delavenne

Blood Adv bloodadvances.2025017898.

https://doi.org/10.1182/bloodadvances.2025017898

Published: 2025

Includes: Supplemental data

Journal Articles

Trp1250, Lys1252, and Arg1367 of ADAMTS13 comprise a hot spot for anti-CUB domain antibodies in patients with iTTP

Tim Postmus, Robin Jansen, Paul Kaijen, Floris van Alphen, Carmen van der Zwaan, Arie J. Hoogendijk, Paul Coppo, Bérangère S. Joly, Agnès Veyradier, Karen Vanhoorelbeke, Gerry Nicolaes, Jan Voorberg

Blood Adv (2025) 9 (20): 5350–5361.

https://doi.org/10.1182/bloodadvances.2025017193

Published: 2025

Includes: Supplemental data

Journal Articles

Updating clinical guidelines with limited evidence: case study of ASH/ISTH pediatric VTE treatment guidelines

Ali Choaib, Aseel AlKhader, Muayad Azzam, Hassan Kawtharany, Marisol Betensky, Leslie Raffini, Rachel Bercovitz, Sara K. Vesely, Paul Monagle, Reem A. Mustafa

Blood Adv (2025) 9 (20): 5347–5349.

https://doi.org/10.1182/bloodadvances.2025017398

Published: 2025

Journal Articles

Incomplete harms reporting in systematic reviews of direct oral factor Xa inhibitors

Jack Rea, Chase Lee, Micah Kee, Brayden Rucker, Holly Flores, Corbin Walters, Taryn Haney, Alicia Tomlin, Adam Khan, Matt Vassar

Blood Adv (2025) 9 (20): 5289–5292.

https://doi.org/10.1182/bloodadvances.2025017363

Published: 2025

Includes: Supplemental data

Journal Articles

Posttransfusion recovery, quality, and metabolism of short- and long-term stored platelets during controlled inflammation

Blood Adv (2025) 9 (20): 5164–5176.

https://doi.org/10.1182/bloodadvances.2025016853

Published: 2025

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Next-generation FVIIIa-mimetic bispecific antibody NXT007: evaluation in preclinical models of hemostasis and thrombosis

Deferral of immunosuppression in acquired hemophilia

Beyond platelet counts: assessing safety of postsplenectomy TPO-RA use in ITP

Diagnosis of von Willebrand disease

FcR γ-chain and platelet hyperactivity

Sustained survival benefit of emicizumab and postponed immunosuppression in acquired hemophilia A

Treatment of von Willebrand Disease

Hypoxia-inducible Factors Contribute to Venous Thrombosis in a Mouse Model of Myeloproliferative Neoplasms

Bleeding and Thrombotic Outcomes in Patients With Inflammatory Bowel Disease and Venous Thromboembolism

Phosphorylation at Y317 on Syk negatively regulates both ITAM- and hemITAM-mediated signaling and function in platelets

Outcomes of patients with suspected heparin-induced thrombocytopenia in a contemporary multicenter cohort

Efficacy and safety of thrombolysis for pediatric venous thromboembolism: a systematic review and meta-analysis

A disrupted adenosinergic axis facilitates platelet activation in APS: exploring a novel therapeutic target

The Na/K-ATPase Alpha-1 Subunit Fine-Tunes Platelet P2Y12 Function and Mediates Sex-Dimorphism-Associated Thrombosis

Pyruvate kinase M2 promotes venous thrombosis by enhancing SNAP23-mediated platelet exocytosis and consequent NETosis

Modeling Response to High-Purity Von Willebrand Factor: Toward Tailored Dosing During Surgery in von Willebrand Disease

Trp1250, Lys1252, and Arg1367 of ADAMTS13 comprise a hot spot for anti-CUB domain antibodies in patients with iTTP

Updating clinical guidelines with limited evidence: case study of ASH/ISTH pediatric VTE treatment guidelines

Incomplete harms reporting in systematic reviews of direct oral factor Xa inhibitors

Posttransfusion recovery, quality, and metabolism of short- and long-term stored platelets during controlled inflammation

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only